title: Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia.
authors.affiliation: Department of Biomedicine, Experimental Hematology, University Hospital Basel, Basel, Switzerland.
authors.forename: Jean
authors.initials: J
authors.lastname: Grisouard
authors.forename: Mario
authors.initials: M
authors.lastname: Ojeda-Uribe
authors.forename: Renate
authors.initials: R
authors.lastname: Looser
authors.forename: Hui
authors.initials: H
authors.lastname: Hao-Shen
authors.forename: Pontus
authors.initials: P
authors.lastname: Lundberg
authors.forename: Adrian
authors.initials: A
authors.lastname: Duek
authors.forename: Eric
authors.initials: E
authors.lastname: Jeandidier
authors.forename: Axel
authors.initials: A
authors.lastname: Karow
authors.forename: Radek C
authors.initials: RC
authors.lastname: Skoda
mesh_terms: D002999:Clone Cells / Q000473:pathology; D000069439:Dasatinib; D005260:Female; D016313:Genes, abl; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D053614:Janus Kinase 2 / Q000235:genetics; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy / Q000235:genetics*; D008875:Middle Aged; D017354:Point Mutation; D011743:Pyrimidines / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use; D013920:Thrombocythemia, Essential / Q000150:complications* / Q000188:drug therapy / Q000235:genetics*; D014178:Translocation, Genetic
chemical_list: D011743:Pyrimidines; D013844:Thiazoles; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D000069439:Dasatinib; D006918:Hydroxyurea